FAVALLI, ANDREA
 Distribuzione geografica
Continente #
EU - Europa 347
NA - Nord America 204
AS - Asia 141
SA - Sud America 5
OC - Oceania 3
Totale 700
Nazione #
US - Stati Uniti d'America 202
IT - Italia 122
DE - Germania 80
SG - Singapore 69
IE - Irlanda 65
CN - Cina 29
RU - Federazione Russa 27
HK - Hong Kong 24
SE - Svezia 16
ID - Indonesia 15
FI - Finlandia 9
NL - Olanda 9
GB - Regno Unito 6
BR - Brasile 5
BE - Belgio 4
AU - Australia 3
AT - Austria 2
CA - Canada 2
IN - India 2
UA - Ucraina 2
AE - Emirati Arabi Uniti 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
FR - Francia 1
MY - Malesia 1
RO - Romania 1
Totale 700
Città #
Frankfurt am Main 70
Dublin 65
Singapore 65
Milan 49
Chandler 28
Ann Arbor 25
Hong Kong 24
New York 22
Santa Clara 20
Shanghai 18
Jakarta 15
Ashburn 11
Florence 8
Helsinki 7
Amsterdam 4
Brussels 4
Los Angeles 4
Piacenza 4
Romola 4
Brescia 3
Chicago 3
Darlington 3
Nuremberg 3
The Bronx 3
Atlanta 2
Bari 2
Bergamo 2
Boardman 2
Carate Brianza 2
Council Bluffs 2
Coventry 2
Fairfield 2
Huizen 2
Lappeenranta 2
London 2
Monza 2
Munich 2
Novate Milanese 2
Princeton 2
Pune 2
Ripalta Cremasca 2
Slough 2
Sulmona 2
São Paulo 2
Vienna 2
Airuno 1
Araranguá 1
Biandronno 1
Bonndorf 1
Brno 1
Casalecchio di Reno 1
Cinisello Balsamo 1
Cuasso al Monte 1
Dallas 1
Dalmine 1
Deiva Marina 1
Dubai 1
Fremont 1
Groningen 1
Lavis 1
Lawrence 1
Melzo 1
Muggiò 1
Notre Dame 1
Ottawa 1
Pavia 1
Petaling Jaya 1
Pioltello 1
Rho 1
Rotterdam 1
Samolaco 1
Santo André 1
Shijiazhuang 1
Sorocaba 1
Toronto 1
Trescore Balneario 1
Washington 1
Wilmington 1
Xi'an 1
Xingtai 1
Zurich 1
Totale 540
Nome #
Integrated longitudinal immunophenotypic, transcriptional and repertoire analyses delineate immune responses in COVID-19 patients 132
Untargeted Mass Spectrometry Approach to Study SARS-CoV-2 Proteins in Human Plasma and Saliva Proteome 131
Plasma proteome investigation of COVID-19 patients with different outcomes through an untargeted label-free LC-MS/MS approach. 86
Untargeted mass spectrometry approach to study SARS-CoV-2 proteins and characterize human plasma and saliva proteome in COVID-19 patients. 81
Plasma Proteomic Variables Related to COVID-19 Severity: An Untargeted nLC-MS/MS Investigation 80
Immunosuppressant Treatment in Rheumatic Musculoskeletal Diseases Does Not Inhibit Elicitation of Humoral Response to SARS-CoV-2 Infection and Preserves Effector Immune Cell Populations 55
Immune response to SARS-CoV-2 natural infection and vaccination in healthy subjects and in immunocompromised patients 47
Corrigendum: The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study(Front. Med., (2022), 9, (850858), 10.3389/fmed.2022.850858) 46
Characterization of SARS-CoV-2 proteins and human proteome in COVID-19 patients’ saliva and plasma: an untargeted mass spectrometry approach 40
Plasma proteomic signatures related to COVID-19 disease severity by an untargeted nLC-ESI-MS/MS approach 35
Totale 733
Categoria #
all - tutte 4.105
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.105


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202235 0 0 0 0 0 0 0 6 1 0 12 16
2022/2023213 15 37 26 50 12 25 5 11 14 6 9 3
2023/2024226 2 9 13 20 18 62 40 14 11 8 4 25
2024/2025259 20 58 39 44 35 34 22 7 0 0 0 0
Totale 733